Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5943 USD | -0.62% | -1.67% | -20.29% |
15/05 | Traws Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
07/05 | Traws Pharma Completes First Cohort Dosed in Phase 1 Trial for COVID Therapy | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.29% | 1.25Cr | |
+46.19% | 5.57TCr | |
+40.06% | 3.99TCr | |
-6.14% | 3.96TCr | |
-6.65% | 2.82TCr | |
+12.33% | 2.63TCr | |
-21.78% | 1.89TCr | |
+28.38% | 1.22TCr | |
+24.18% | 1.21TCr | |
-0.35% | 1.21TCr |
- Stock Market
- Equities
- TRAW Stock
- News Traws Pharma, Inc.
- Transcript : Onconova Therapeutics, Inc. - Shareholder/Analyst Call